Chong Shen
- Molecular Biology
- Immunology top 10%
- Genetics top 10%
- Biomedical Engineering
- Surgery
- Co-authors
- Jan CeuppensGert Van AsschePaul RutgeertsStefaan ColpaertDominique BullensKarel GeboesRohit KarnikJeffrey M. Karp
- Topics
- Bladder and Urothelial Cancer Treatments (18 papers)Ferroptosis and cancer prognosis (16 papers)Inflammatory Bowel Disease (10 papers)
- Cited by
- ImmunologyMolecular BiologyAging
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaBelgiumUnited States
In The Last Decade
Chong Shen
78 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 114
- Molecular Biology 668
- Immunology 314
- Genetics 245
- Biomedical Engineering 218
- Surgery 141
Countries citing papers authored by Chong Shen
This map shows the geographic impact of Chong Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong Shen more than expected).
Fields of papers citing papers by Chong Shen
This network shows the impact of papers produced by Chong Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong Shen. The network helps show where Chong Shen may publish in the future.
Co-authorship network of co-authors of Chong Shen
This figure shows the co-authorship network connecting the top 25 collaborators of Chong Shen. A scholar is included among the top collaborators of Chong Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chong Shen. Chong Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 6 | |
| 8 | 3 | |
| 9 | 6 | |
| 10 | 0 | |
| 11 | 2 | |
| 12 | 5 | |
| 13 | 11 | |
| 14 | 10 | |
| 15 | Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma | 4 |
| 16 | 10 | |
| 17 | 53 | |
| 18 | A fully human anti-TNF mAb adalimumab (D2E7) induces caspase-dependent apoptosis of human peripheral blood monocyte and T cells | 2 |
| 19 | 14 | |
| 20 | In vitro analysis of IGN-gamma and IL-12 production and their effects in ileal Crohn’s disease | 1 |
About Chong Shen
Chong Shen is a scholar working on Aging, Cancer Research and Immunology, having authored 91 papers that have together received 1.4k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (18 papers), Ferroptosis and cancer prognosis (16 papers) and Inflammatory Bowel Disease (10 papers). The work is most often cited by research in Immunology (314 citations), Molecular Biology (668 citations) and Aging (16 citations). Chong Shen has collaborated with scholars based in China, Belgium and United States. Frequent co-authors include Jan Ceuppens, Gert Van Assche, Paul Rutgeerts, Stefaan Colpaert, Dominique Bullens, Paul Rutgeerts, Karel Geboes, Rohit Karnik, Jeffrey M. Karp and Suman Bose. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.